Summary
The Saskatchewan Drug Plan proposed de-listing sevcml second-line antibiotics from its formulary for reasons of potential overuse and expense. This study evaluated the use of second-line antibiotics as initial and secondary courses of therapy depending un the patient’s prior use of other antibiotics and other factors. A total of 637 607 courses of therapy dispensed to Plan members for selected antibiotics between July 1989 and June 1990 were evaluated.
Second-line antibiotics were used in 5.0% of all initial courses of therapy. This use was correlated with patient characteristics that may warrant use of second-line antibiotics as initial therapy: age, rural residence. the use of bronchodilators or inhaled steroids, and the number of prior courses of antibiotic therapy.
The potential savings from de-listing second-line Antibiotics from the formulary are limited because of their use in only 5% of initial courses of therapy. Savings would be further reduced by administrative costs and physician time required to process prior authorisation requests and the costs of treating any additional antibiotic treatment failures that may result from reduced access
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Health economics in Canada: fact sheet. Policy and Planning Information Branch, Deparment of Health and Welfare. Canada. Mar 1992
Handbook on antimicrobial therapy: the medical letter diagnostics and therapeutics. Rev ed. New Rochelle: Medical Letter,Inc., 1990
Shulman ST, Phair JB, Sommers HM, editors. The biological and clinical basis of infectious diseases. Philadelphia: W.B.Saunders Company, 1992
Skoll SL, August RJ, Johnson GE. Drug prescribing for the elderly in Saskatchewan in J976. Can Med Assoc J 1979 Oct 20; 121: 1074–81
West R, Sherman GJ, Downey W. A record linkage study of valproate and malformations in Saskatchewan. Can J Puh Health 1985 Jul/Aug; 76: 226–8
Hogan DJ, Strand LM, Lane PR. Isotretinoin therapy for acne: a population–based study. Can Med Assoc J 1988 Jan 1:138: 47–50
Ray WA, Downey W, Griffin M, et al. Long–term use of thiazide diuretics and risk of hip fracture. Lancet 1989 Apr 1;1: 687–90
Thiessen BQ, Wallace SM, Blackburn J, et al. Increased prescribi ng of antidepressants subsequent to beta–blocker therapy. Arch Intern Med 1990 Nov; 150: 2286–90
Ray WA, Griffin MR, Downey W. Benz Odiazepines of long and short elimination half–life and the risk of hip fracture. JAMA 1989 Dec 15; 262 (23): 3303–7
Von Korff M, Wagner E, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992; 15 (2): 197–203
McCombs JS, Nichol MB, Pharmacy–enforced outpatient drug treatment protocols:a case study of Medical restrictions for cefaclor. Ann Pharmacother 1993 Feb; 27 (2): 155–60
McCombs JS, Nichol ML, Stimmel GL,et al. The costt of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. J Clin Psychiatry 1990 Jun; 51 Surpl.: 60–9
McCombs JS, Nichol MB, Newman CM, et al. The cost of interupting antihypertensive drug therapy in a Medicaid population. Med Care 1994 Mar; 32 (3): 214–26
McCombs JS, Nichol MB, Sclar DA. Single–pharmacy patronage and adverse drug reactions: a case study of cimetidine. J Res Pharm Econ 1993; 5 (1): 3–24
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCombs, J.S., Nichol, M.B. The Use of First- and Second-Line Outpatient Antibiotics Under the Saskatchewan Drug Plan. Pharmacoeconomics 7, 543–554 (1995). https://doi.org/10.2165/00019053-199507060-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199507060-00008